• レポートコード:QY20ST-06391 • 出版社/出版日:QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、137ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の犬用処方薬市場について種類別(オーラルタイプ、スミアタイプ、インジェクションタイプ、スプレータイプ)、用途別(病院、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・犬用処方薬市場の概要 ・世界の主要地域別犬用処方薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の犬用処方薬市場規模2015-2026:種類別(オーラルタイプ、スミアタイプ、インジェクションタイプ、スプレータイプ) ・世界の犬用処方薬市場規模2015-2026:用途別(病院、クリニック、その他) ・犬用処方薬の北米市場規模2015-2020 ・犬用処方薬のヨーロッパ市場規模2015-2020 ・犬用処方薬の中国市場規模2015-2020 ・犬用処方薬の日本市場規模2015-2020 ・犬用処方薬の東南アジア市場規模2015-2020 ・犬用処方薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・犬用処方薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・犬用処方薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Dog Prescription Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Dog Prescription Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Dog prescription drug is a kind of animal prescription. Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal’s physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Dog Prescription Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Dog Prescription Drugs industry.
Based on our recent survey, we have several different scenarios about the Dog Prescription Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Dog Prescription Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Dog Prescription Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Dog Prescription Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Dog Prescription Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Dog Prescription Drugs market. The report also includes nautical information, where it shows Dog Prescription Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Dog Prescription Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Dog Prescription Drugs market.
Geographical Analysis:
Based on region, the global Dog Prescription Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Dog Prescription Drugs market are
Elanco Animal Health
Ceva Sante Animale
MSD Animal Health
Zoetis
Virbac
Dechra
Vetoquinol
Animalcare Group
Ourofino Saude Animal
Boehringer Ingelheim
Segment by Type
Oral Type
Smear Type
Injection Type
Spray Type
Segment by Application
Hospital
Clinic
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Dog Prescription Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Dog Prescription Drugs market.
• The market share of the global Dog Prescription Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Dog Prescription Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Dog Prescription Drugs market.
1 Dog Prescription Drugs Market Overview
1.1 Dog Prescription Drugs Product Scope
1.2 Dog Prescription Drugs Segment by Type
1.2.1 Global Dog Prescription Drugs Sales by Type (2020-2026)
1.2.2 Oral Type
1.2.3 Smear Type
1.2.4 Injection Type
1.2.5 Spray Type
1.3 Dog Prescription Drugs Segment by Application
1.3.1 Global Dog Prescription Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Dog Prescription Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dog Prescription Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Dog Prescription Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Dog Prescription Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Dog Prescription Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Dog Prescription Drugs Industry
1.5.1.1 Dog Prescription Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dog Prescription Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dog Prescription Drugs Players to Combat Covid-19 Impact
2 Dog Prescription Drugs Estimate and Forecast by Region
2.1 Global Dog Prescription Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dog Prescription Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dog Prescription Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Dog Prescription Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dog Prescription Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dog Prescription Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dog Prescription Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Dog Prescription Drugs Estimates and Projections (2015-2026)
2.4.3 China Dog Prescription Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Dog Prescription Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dog Prescription Drugs Estimates and Projections (2015-2026)
2.4.6 India Dog Prescription Drugs Estimates and Projections (2015-2026)
3 Global Dog Prescription Drugs Competition Landscape by Players
3.1 Global Top Dog Prescription Drugs Players by Sales (2015-2020)
3.2 Global Top Dog Prescription Drugs Players by Revenue (2015-2020)
3.3 Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Prescription Drugs as of 2019)
3.4 Global Dog Prescription Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Dog Prescription Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dog Prescription Drugs Players (Opinion Leaders)
4 Global Dog Prescription Drugs Market Size by Type
4.1 Global Dog Prescription Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Dog Prescription Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Dog Prescription Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Dog Prescription Drugs Price by Type (2014-2020)
4.2 Global Dog Prescription Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dog Prescription Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Dog Prescription Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Dog Prescription Drugs Price Forecast by Type (2021-2026)
5 Global Dog Prescription Drugs Market Size by Application
5.1 Global Dog Prescription Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Dog Prescription Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Dog Prescription Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Dog Prescription Drugs Price by Application (2015-2020)
5.2 Global Dog Prescription Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dog Prescription Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Dog Prescription Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Dog Prescription Drugs Price Forecast by Application (2021-2026)
3 North America Dog Prescription Drugs Market Facts & Figures
3.2 North America Dog Prescription Drugs Sales Market Share by Company (2015-2020)
3.3 North America Dog Prescription Drugs Sales Market Share by Type (2015-2020)
3.4 North America Dog Prescription Drugs Sales Market Share by Application (2015-2020)
4 Europe Dog Prescription Drugs Market Facts & Figures
4.2 Europe Dog Prescription Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Dog Prescription Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Dog Prescription Drugs Sales Market Share by Application (2015-2020)
5 China Dog Prescription Drugs Market Facts & Figures
5.2 China Dog Prescription Drugs Sales Market Share by Company (2015-2020)
5.3 China Dog Prescription Drugs Sales Market Share by Type (2015-2020)
5.4 China Dog Prescription Drugs Sales Market Share by Application (2015-2020)
6 Japan Dog Prescription Drugs Market Facts & Figures
6.2 Japan Dog Prescription Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Dog Prescription Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Dog Prescription Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Dog Prescription Drugs Market Facts & Figures
7.2 Southeast Asia Dog Prescription Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dog Prescription Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dog Prescription Drugs Sales Market Share by Application (2015-2020)
8 India Dog Prescription Drugs Market Facts & Figures
8.2 India Dog Prescription Drugs Sales Market Share by Company (2015-2020)
8.3 India Dog Prescription Drugs Sales Market Share by Type (2015-2020)
8.4 India Dog Prescription Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dog Prescription Drugs Business
12.1 Elanco Animal Health
12.1.1 Elanco Animal Health Dog Prescription Drugs Corporation Information
12.1.2 Elanco Animal Health Dog Prescription Drugs Business Overview and Total Revenue
12.1.3 Elanco Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Elanco Animal Health Dog Prescription Drugs Products Offered
12.1.5 Elanco Animal Health Recent Development
12.2 Ceva Sante Animale
12.2.1 Ceva Sante Animale Dog Prescription Drugs Corporation Information
12.2.2 Ceva Sante Animale Dog Prescription Drugs Business Overview and Total Revenue
12.2.3 Ceva Sante Animale Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Ceva Sante Animale Dog Prescription Drugs Products Offered
12.2.5 Ceva Sante Animale Recent Development
12.3 MSD Animal Health
12.3.1 MSD Animal Health Dog Prescription Drugs Corporation Information
12.3.2 MSD Animal Health Dog Prescription Drugs Business Overview and Total Revenue
12.3.3 MSD Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 MSD Animal Health Dog Prescription Drugs Products Offered
12.3.5 MSD Animal Health Recent Development
12.4 Zoetis
12.4.1 Zoetis Dog Prescription Drugs Corporation Information
12.4.2 Zoetis Dog Prescription Drugs Business Overview and Total Revenue
12.4.3 Zoetis Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Zoetis Dog Prescription Drugs Products Offered
12.4.5 Zoetis Recent Development
12.5 Virbac
12.5.1 Virbac Dog Prescription Drugs Corporation Information
12.5.2 Virbac Dog Prescription Drugs Business Overview and Total Revenue
12.5.3 Virbac Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Virbac Dog Prescription Drugs Products Offered
12.5.5 Virbac Recent Development
12.6 Dechra
12.6.1 Dechra Dog Prescription Drugs Corporation Information
12.6.2 Dechra Dog Prescription Drugs Business Overview and Total Revenue
12.6.3 Dechra Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dechra Dog Prescription Drugs Products Offered
12.6.5 Dechra Recent Development
12.7 Vetoquinol
12.7.1 Vetoquinol Dog Prescription Drugs Corporation Information
12.7.2 Vetoquinol Dog Prescription Drugs Business Overview and Total Revenue
12.7.3 Vetoquinol Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Vetoquinol Dog Prescription Drugs Products Offered
12.7.5 Vetoquinol Recent Development
12.8 Animalcare Group
12.8.1 Animalcare Group Dog Prescription Drugs Corporation Information
12.8.2 Animalcare Group Dog Prescription Drugs Business Overview and Total Revenue
12.8.3 Animalcare Group Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Animalcare Group Dog Prescription Drugs Products Offered
12.8.5 Animalcare Group Recent Development
12.9 Ourofino Saude Animal
12.9.1 Ourofino Saude Animal Dog Prescription Drugs Corporation Information
12.9.2 Ourofino Saude Animal Dog Prescription Drugs Business Overview and Total Revenue
12.9.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ourofino Saude Animal Dog Prescription Drugs Products Offered
12.9.5 Ourofino Saude Animal Recent Development
12.10 Boehringer Ingelheim
12.10.1 Boehringer Ingelheim Dog Prescription Drugs Corporation Information
12.10.2 Boehringer Ingelheim Dog Prescription Drugs Business Overview and Total Revenue
12.10.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Boehringer Ingelheim Dog Prescription Drugs Products Offered
12.10.5 Boehringer Ingelheim Recent Development
13 Dog Prescription Drugs Manufacturing Cost Analysis
13.1 Dog Prescription Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dog Prescription Drugs
13.4 Dog Prescription Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dog Prescription Drugs Distributors List
14.3 Dog Prescription Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dog Prescription Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Dog Prescription Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Dog Prescription Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Dog Prescription Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Dog Prescription Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Dog Prescription Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Dog Prescription Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Dog Prescription Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Dog Prescription Drugs Revenue Share by Region (2015-2020)
Table 13. Global Dog Prescription Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Dog Prescription Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Dog Prescription Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Dog Prescription Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Dog Prescription Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Dog Prescription Drugs Sales Share by Company (2015-2020)
Table 19. Global Dog Prescription Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Dog Prescription Drugs Revenue Share by Company (2015-2020)
Table 21. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Prescription Drugs as of 2019)
Table 22. Global Dog Prescription Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Dog Prescription Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Dog Prescription Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Dog Prescription Drugs Players
Table 27. Global Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Dog Prescription Drugs Sales Share by Type (2015-2020)
Table 29. Global Dog Prescription Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Dog Prescription Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Dog Prescription Drugs Sales Share by Type (2021-2026)
Table 32. Global Dog Prescription Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Dog Prescription Drugs Revenue Share by Type (2021-2026)
Table 34. Global Dog Prescription Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Dog Prescription Drugs Sales Share by Application (2015-2020)
Table 37. Global Dog Prescription Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Dog Prescription Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Dog Prescription Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Dog Prescription Drugs Sales Share by Application (2021-2026)
Table 41. Global Dog Prescription Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Dog Prescription Drugs Revenue Share by Application (2021-2026)
Table 43. Global Dog Prescription Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Dog Prescription Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Dog Prescription Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Dog Prescription Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Dog Prescription Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 56. China Dog Prescription Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Dog Prescription Drugs Sales Market Share by Company (2015-2020)
Table 58. China Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 60. China Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Dog Prescription Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Dog Prescription Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Dog Prescription Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Dog Prescription Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 74. India Dog Prescription Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Dog Prescription Drugs Sales Market Share by Company (2015-2020)
Table 76. India Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 78. India Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 80. Elanco Animal Health Corporation Information
Table 81. Elanco Animal Health Description and Business Overview
Table 82. Elanco Animal Health Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Elanco Animal Health Dog Prescription Drugs Product
Table 84. Elanco Animal Health Recent Development
Table 85. Ceva Sante Animale Corporation Information
Table 86. Ceva Sante Animale Description and Business Overview
Table 87. Ceva Sante Animale Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Ceva Sante Animale Dog Prescription Drugs Product
Table 89. Ceva Sante Animale Recent Development
Table 90. MSD Animal Health Corporation Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. MSD Animal Health Dog Prescription Drugs Product
Table 94. MSD Animal Health Recent Development
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Zoetis Dog Prescription Drugs Product
Table 99. Zoetis Recent Development
Table 100. Virbac Corporation Information
Table 101. Virbac Description and Business Overview
Table 102. Virbac Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Virbac Dog Prescription Drugs Product
Table 104. Virbac Recent Development
Table 105. Dechra Corporation Information
Table 106. Dechra Description and Business Overview
Table 107. Dechra Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Dechra Dog Prescription Drugs Product
Table 109. Dechra Recent Development
Table 110. Vetoquinol Corporation Information
Table 111. Vetoquinol Description and Business Overview
Table 112. Vetoquinol Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Vetoquinol Dog Prescription Drugs Product
Table 114. Vetoquinol Recent Development
Table 115. Animalcare Group Corporation Information
Table 116. Animalcare Group Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Animalcare Group Description and Business Overview
Table 118. Animalcare Group Dog Prescription Drugs Product
Table 119. Animalcare Group Recent Development
Table 120. Ourofino Saude Animal Corporation Information
Table 121. Ourofino Saude Animal Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Ourofino Saude Animal Description and Business Overview
Table 123. Ourofino Saude Animal Dog Prescription Drugs Product
Table 124. Ourofino Saude Animal Recent Development
Table . Boehringer Ingelheim Corporation Information
Table . Boehringer Ingelheim Description and Business Overview
Table . Boehringer Ingelheim Dog Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Boehringer Ingelheim Dog Prescription Drugs Product
Table . Boehringer Ingelheim Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Dog Prescription Drugs Distributors List
Table 133. Dog Prescription Drugs Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Prescription Drugs Product Picture
Figure 2. Global Dog Prescription Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dog Prescription Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Dog Prescription Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Dog Prescription Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Dog Prescription Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Dog Prescription Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Dog Prescription Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Dog Prescription Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Dog Prescription Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Dog Prescription Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Dog Prescription Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Dog Prescription Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Dog Prescription Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Dog Prescription Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Dog Prescription Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dog Prescription Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Dog Prescription Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Dog Prescription Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Dog Prescription Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Dog Prescription Drugs Players Market Share by Revenue in Dog Prescription Drugs 2015 & 2019
Figure 27. Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Dog Prescription Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Dog Prescription Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Dog Prescription Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Dog Prescription Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 33. United States Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 34. Europe Dog Prescription Drugs Sales Market Share by Company in 2019
Figure 35. Europe Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 36. Europe Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 37. China Dog Prescription Drugs Sales Market Share by Company in 2019
Figure 38. China Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 39. China Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 40. Japan Dog Prescription Drugs Sales Market Share by Company in 2019
Figure 41. Japan Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 42. Japan Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Dog Prescription Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 46. India Dog Prescription Drugs Sales Market Share by Company in 2019
Figure 47. India Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 48. India Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 49. Elanco Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. MSD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Dechra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Animalcare Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ourofino Saude Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Dog Prescription Drugs
Figure 61. Manufacturing Process Analysis of Dog Prescription Drugs
Figure 62. Dog Prescription Drugs Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed